Category: Health Services

The global pharmaceutical continuous manufacturing market is likely to surge at a CAGR of 10.35% during the forecast years 2021-2028. Further, the market acquired $369.1 million in 2020, and is expected to attain revenue worth $937.7 million by 2028. The continuous pharmaceutical manufacturing systems provide significant advantages, such as reduced production fluctuation, improved yields, low cost of operation and equipment, thereby fueling the studied market’s growth.